Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Sebana Medical is a biopharmaceutical company developing a new type of dermal filler. The goal of the product is to prevent fat cell reabsorption following soft tissue augmentation. Sebana's formulation is designed to be incorporated with the autologous fat during the fat-grafting procedure. This formulation has the ability to release its active drug ingredient locally and gradually in the injected fat to prevent fat cell reabsorption during the critical period after fat transplantation. The company's drug has the potential to address and treat a variety of common medical conditions, including soft tissue reconstructions due to congenital malformation and mastectomy, and cosmetic procedures such as wrinkle removal and breast augmentation.